Who is sponsoring NCT04726865?

NCT04726865 is sponsored by University of Jordan.

What drugs are being tested in NCT04726865?

Interventions in NCT04726865: Naser Al-Husban.

What condition does NCT04726865 study?

NCT04726865 studies the Effect of COVID-19 Pandemic.

Is NCT04726865 still recruiting?

NCT04726865 is currently completed. Last updated 27 January 2021.

Last reviewed 2021-01-27 · How we verify

NCT04726865

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Pandemic and Medical Students

Completed Last updated 27 January 2021

What this trial tests

trial testing Naser Al-Husban in the Effect of COVID-19 Pandemic in 415 participants. Completed in 31 December 2020.

Timeline

1 October 2020

Primary endpoint
20 December 2020

31 December 2020

Quick facts

Lead sponsor	University of Jordan
Status	Completed
Study type	OBSERVATIONAL
Enrollment	415
Start date	1 October 2020
Primary completion	20 December 2020
Estimated completion	31 December 2020
Sites	1 location across Jordan

Drugs / interventions tested

Naser Al-Husban — full drug profile →

Conditions studied

the Effect of COVID-19 Pandemic — all drugs for the Effect of COVID-19 Pandemic →

Sponsor

University of Jordan

Who can join

Adults 18 to 24, any sex, with the Effect of COVID-19 Pandemic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Little is known about changes in levels of academic, financial, psychological, \& hygienic impact on medical students during this pandemic.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of COVID-19 pandemic on medical students in Jordanian universities: A multi-center cross-sectional study.
Al-Husban N, Alkhayat A, Aljweesri M, Alharbi R, et al · · 2021 · cited 19× · PMID 34168869 · DOI 10.1016/j.amsu.2021.102466

Verify or expand the search:

Other trials of Naser Al-Husban

Trials testing the same drug.

NCT05688995 — COVID-19 Vaccines and the Menstrual Cycle · completed
NCT05595512 — Postpartum Depression · completed

Other University of Jordan trials

Trials by the same sponsor.

NCT07370545 — Impact of Presentation Sequence on Patient Tooth Shade Selection · NA · completed
NCT07279285 — Sweet-Tasting Solution Versus Placebo to Reduce Pain During Local Anesthetic Injection in Children · NA · not yet recruiting
NCT07310485 — Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa · NA · enrolling by invitation
NCT06977009 — Influence of Occlusal Reduction on Endodontic Postoperative Pain · NA · recruiting
NCT07212413 — Effect of Snow-plow Technique on the Postoperative Pain Following Direct Composite Restoration · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04726865 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Jordan
Last refreshed: 27 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04726865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing